DOI: 10.12890/2025_005286

Improvement of microangiopathy in a systemic sclerosis patient following hysterectomy for leiomyoma: a potential role of neoplasia

Authors

  • Angelo Nigro Department of Rheumatology of Lucania, UOSD of Rheumatology, “Madonna delle Grazie” Hospital, Matera, Italy
  • Pasquale Santarcangelo Internal Medicine, “Madonna delle Grazie” Hospital, Matera, Italy
  • Antonio Bonelli Internal Medicine, “Madonna delle Grazie” Hospital, Matera, Italy
  • Serena Digregorio Internal Medicine, “Madonna delle Grazie” Hospital, Matera, Italy
  • Carmela Mazzoccoli Internal Medicine, “Madonna delle Grazie” Hospital, Matera, Italy
  • Giuseppe Nicoletti Internal Medicine, “Madonna delle Grazie” Hospital, Matera, Italy

angelonigro13@gmail.com

Keywords

Systemic sclerosis, microangiopathy, neoplasia, Raynaud’s phenomenon, capillaroscopy

Abstract

Background: Systemic sclerosis (SSc) is a complex autoimmune disease characterised by vascular alterations, immune dysregulation and fibrosis. Microangiopathy is a hallmark of SSc and can be assessed non-invasively using nailfold videocapillaroscopy (NVC).
Case description: This is a case of a 50-year-old Caucasian woman with anticentromere-positive SSc, experiencing Raynaud’s phenomenon and hand oedema. She met the 2013 ACR/EULAR classification criteria for SSc. Despite stable nifedipine therapy, her vasospastic episodes were only partially controlled. In March 2024, she underwent a total hysterectomy for a symptomatic uterine leiomyoma. Postoperatively, there was a marked improvement in Raynaud’s phenomenon and NVC findings.
Discussion: This case suggests a potential link between neoplastic processes and exacerbation of SSc-related microangiopathy. It is hypothesised that tumour-derived factors, such as inflammatory cytokines and angiogenic mediators, may contribute to endothelial dysfunction and worsen vascular impairment. The observed microvascular improvement following tumour removal supports the hypothesis that neoplasms may act as disease-modifying factors in SSc. Further studies are needed to determine whether systematic malignancy screening in selected SSc patients may help identify modifiable triggers of microangiopathy.

View the entire article

Downloads

References

  1. Denton CP, Khanna D. Systemic sclerosis. Lancet 2017;390:1685–1699.
  2. Smith V, Ickinger C, Hysa E, Snow M, Frech T, Sulli A, et al. Nailfold capillaroscopy. Best Pract Res Clin Rheumatol 2023;37:101849.
  3. Hysa E, Pizzorni C, Sammorì S, Gotelli E, Cere A, Schenone C, et al. Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging. RMD Open 2023;9:e003071.
  4. Shah AA, Rosen A. Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications. Curr Opin Rheumatol 2011;23:530–535.
  5. Hemminki K, Huang W, Sundquist J, Sundquist K, Ji J. Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence. Semin Cancer Biol 2020;64:114–121.
  6. Treppo E, Toffolutti F, Manfrè V, Taborelli M, De Marchi G, De Vita S, et al. Risk of cancer in connective tissue diseases in Northeastern Italy over 15 Years. J Clin Med 2022;11:4272.

Published

2025-03-26

How to Cite

1.
Nigro A, Santarcangelo P, Bonelli A, Digregorio S, Mazzoccoli C, Nicoletti G. Improvement of microangiopathy in a systemic sclerosis patient following hysterectomy for leiomyoma: a potential role of neoplasia. EJCRIM [Internet]. 2025 Mar. 26 [cited 2026 Nov. 3];12(4). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5286